The Chinese pharmaceutical sector has significantly outperformed the broader market this year, driven by strong sales growth and a rapid increase in income from licensing drugs to international partners, according to HSBC.

📰

Continue Reading on South China Morning Post

This preview shows approximately 15% of the article. Read the full story on the publisher's website to support quality journalism.

Read Full Article →